Purchase Order 75F40124P00236
Award Date 8/12/24
Potential Completion Date 5/19/25
Potential Value $98K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rochester, NY 14623, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Food and Drug Administration (FDA) to Litron Laboratories LTD, a for-profit biotechnology company registered as a subchapter S corporation. The $4,624 firm fixed-price purchase order is for the delivery of a MICRONUCELUS ASSAY KIT, which supports the FDA's National Center for Toxicological Research (NCTR) in conducting genotoxicity research. The contract does not have a set-aside designation, indicating open competition. Litron Laboratories is a...
- This is a $29,665.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Litron Laboratories LTD, a for-profit biotechnology company based in Rochester, New York. The contract is for the delivery of LITRON MULTIFLOW AND MICROFLOW KITS, which are specialized research-oriented assay kits used for investigating genotoxic effects and conducting detailed analytical research on chemical exposures. The contract has an ultimate completion date of September 30,...
- This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Litron Laboratories LTD, a for-profit biotechnology company registered as a subchapter S corporation. The $23,989.00 contract is for the delivery of LITRON PLUS-R INVIVO and PLUS-RBM INVIVO MICROFLOW KITS, with an ultimate completion date of September 30, 2025. The award was made on July 1, 2025 and did not utilize any set-aside designations, indicating open competition. Litron Laboratories is a...
- The Department of Health and Human Services Food and Drug Administration awarded a $24,744.00 firm fixed price purchase order to Litron Laboratories Ltd, a for-profit subchapter S corporation biotechnology company, for the delivery of 6 LITRON IN-VITRO MICROFLOW ASSAY KITS. The contract has a completion date of June 16, 2024 and was awarded on May 17, 2024. No set-aside was used. Litron Laboratories specializes in using flow cytometry to analyze DNA damage and has previously provided similar...
- This firm-fixed-price delivery order was issued under the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The $1,412,105.00 contract was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute, a non-profit contract research organization. The contract is for the...
- This firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a for-profit research and testing services company. The contract, valued at $88,156.00, is for a pilot study on the in vivo genetic toxicity of the chemical NNK (nicotine-derived nitrosamine ketone) in mice using the intraperitoneal route of administration. This contract is part of a larger $7.8 million indefinite delivery contract (IDC) awarded by...
- This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit research organization, to develop a standard guideline protocol for rodent tobacco smoke inhalation studies. The contract has a ceiling value of $1,373,599.00 and is a firm fixed-price task order issued under the "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The...
- This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization, to conduct in vitro evaluation of the toxic profiles of tobacco additives in a systematic tiered approach. The contract has a ceiling value of $1,552,162.00 and an ultimate completion date of July 14, 2018. It was issued under the FDA's "In Vivo Toxicology of Tobacco...
- This is a $184,641.98 firm-fixed-price purchase order contract awarded by the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) to Smithers Viscient LLC, a veteran-owned small business. The contract is for an animal food residue study conducted under the U.S. Environmental Protection Agency's (EPA) Good Laboratory Practice (GLP) standards for the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). The study involves detecting nitrite and...
- This is a $1,847,030 delivery order contract awarded by the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization. The contract is for comparative pharmacokinetics and in vivo genetic toxicology studies of N-Nitrosonornicotine (NNN) in rats. The work is being performed under the FDA's "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract has a firm fixed price...